Insight Molecular Diagnostics Inc. - 8-K Filing

Insight Molecular Diagnostics Inc. enters into underwriting agreement for $15.0 million public offering of common stock and pre-funded warrants. (Items: 1.01 Entry into a Material Definitive Agreement, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $IMDX

Read the full article at SEC EDGAR

Part of the story Rezolute, Inc. - 8-K Filing (7 articles)

More Regulatory news